News | March 09, 2008

New Dual-Energy Applications Target Heart, Brain, Lung

March 10, 2008 - The FDA gave Siemens 510(k) market clearance of four new software applications used with the SOMATOM Definition aimed at simplifying the diagnosis of diseases of the heart, brain, lungs and extremity joints, as announced at ECR 2008, currently being held in Vienna.

One of the new dual energy applications for the SOMATOM Definition, a dual-source computed tomography (CT) system, is syngo DE Heart PBV (Perfusion Blood Volume), which reportedly provides color-marking of non-perfused parts of the myocardium during cardiology examinations. Moreover, syngo DE Heart PBV is designed to enable the isolated display of the heart, for example, without thorax structures. The heart perfusion is examined primarily after an infarction to determine damaged areas of the organ. DECT is said to detect a stenosis and its degree, as well as the location and extent of the resulting reduced perfusion in the myocardium in a single scan.
Deposits of uric acid crystals in the joints of gout patients may damage the cartilaginous and osseous substance, particularly if the disease has been chronic for several years. With syngo DE Gout, CT can reportedly be used for gout detection. The new dual energy application is engineered to assist the physician in clearly identifying uric acid crystals in the extremities and monitoring changes in the crystals in the course of treatment.
With syngo DE Lung Vessels a series of applications are available to assist the physician in CT examinations of patients with suspected pulmonary embolism. The new applications enable the detection of non-perfused blood vessels and tissue of the lungs through color-marking. The lung isolation application isolates the entire organ to allow the assessment of the perfusion situation without obstructing neighboring organs.
syngo DE Brain Hemorrhage assists in the distinction between new and old hemorrhages in the event of cerebral bleeding. The two energy levels of the X-ray tubes are used to fade out the contrast medium (CM). In the past, this had required two scans. The contrast medium subtraction offers two advantages: A non-contrast medium enhanced examination is not necessary, and the patient is spared the dose of a second scan.

The four new dual energy applications presented by Siemens at the ECR 2008 supplement the six existing CT applications with dual energy features:

- syngo DE Direct Angio for the distinction of bone and vessel structures, particularly if the vessels are located directly next to the bone
- syngo DE Lung PBV for perfusion assessment of the lung tissue
- syngo DE Musculoskeletal for the display of ligaments and tendons
- syngo DE Calculi Characterization for the automatic distinction of the biochemical composition of renal calculi (e.g., uric acid or calcium oxalate)
- syngo DE Hardplaque for the display of calcification in the body and determination of the vessel status
- syngo DE Virtual Unenhanced for the subtraction of contrast medium in abdominal scans

For more information: www.usa.siemens.com/medical

Related Content

Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
Key Patient Preparations for a CT Scan
News | Computed Tomography (CT) | September 05, 2018
The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
Videos | Computed Tomography (CT) | July 23, 2018
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiova
Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
FFR-CT may soon replace invasive angiography for coronary lesion assessment. #EuroPCR 

Anexample of a clinical case of CT-FFR, which can derive the FFR numbers for their entire coronary tree using a noninvasive CT scan.

Feature | Computed Tomography (CT) | May 29, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial [1] underline the effectiveness of evolving no
James Min Named Editor-in-Chief of Journal of Cardiovascular Computed Tomography
News | Computed Tomography (CT) | May 01, 2018
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of...
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
April 18, 2018 — The U.S.
Overlay Init